News

Regeneron Pharmaceuticals Inc. is adding to its obesity pipeline by in-licensing Hansoh Biomedical Co. Ltd.’s phase III dual glucagon-like peptide 1 (GLP-1)/gastric inhibitory polypeptide (GIP) ...
A total of 474 participants were randomly assigned to the durvalumab group, and 474 to the placebo group (median follow-up, 31.5 months; interquartile range, 26.7 to 36.6). Two-year event-free ...
Mounjaro mimics two key hormones: Glucagon-like peptide-1 (GLP-1) and Gastric inhibitory polypeptide (GIP). These hormones help regulate blood sugar, control appetite, and slow digestion, making ...
To determine whether the natriuretic peptide receptor (NPR) is present in the stomach of guinea pigs and to investigate the effect of dendroaspis natriuretic peptide (DNP) on the gastric motility ...
How is Mounjaro different from Ozempic? The main difference seems to be that Mounjaro has actually been approved as a weight-management medication, while Ozempic has not. As for their active substance ...
KAWASAKI, Japan, December 12, 2024--We are planning to initiate human Ph0 imaging studies of 64Cu-PD-29875, highly-selective peptide-RI conjugate against Claudin 18.2, in 2025.
We are planning to initiate human Ph0 imaging studies of 64Cu-PD-29875, highly-selective peptide-RI conjugate against Claudin 18.2, in 2025.
Nauck, M.A., Baller, B. and Meier, J.J. (2004) Gastric Inhibitory Polypeptide and Glucagon-Like Peptide-1 in the Pathogenesis of Type 2 Diabetes. Diabetes, 53, S190-S196.
Given that there was no statistically significant change in the anticoagulant activity of the hirudo extract following incubation with pepsin for 30 and 60 min (p > 0.05, with activity being higher at ...
Peptides in Tissue Research and Gastric Wound Studies In addition to their possible regulatory impacts on enzyme activity and microbial populations, peptides are being investigated for their potential ...
Oct 18 (Reuters) - The U.S. Food and Drug Administration approved Astellas' (4503.T), opens new tab therapy to treat a type of gastric cancer, the health regulator's website showed on Friday. The ...